[{"Assets_0_Q3_USD":444588000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":138178000.0,"NetIncomeLoss_1_Q3_USD":226086000.0,"NetIncomeLoss_3_Q3_USD":181271000.0,"StockholdersEquity_0_Q3_USD":164712000.0,"EarningsPerShareBasic_1_Q3_USD":2.13,"EarningsPerShareBasic_3_Q3_USD":1.71,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":106272000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":106200000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]